FOLR1 and ovarian cancer: MOv18 IgE, specific for the ovarian cancer-associated antigen folate receptor alpha (FRα) enhanced the survival of patient-derived orthotopically-grown ovarian cancer xenograft-bearing mice reconstituted with human immune cells, but only when monocytes were present in the immune effector cell population [8].